SPEED Study: (Susceptibility Provision Enhances Effective De-escalation): Evaluation of the Accelerate PhenoTM System in patients with GNR Bacteremia
-
- STATUS
- Not Recruiting
Summary
A performance verification study with The Accelerate PhenoTM System will potentially address the ongoing concerns with widespread antimicrobial resistance. Our proposed ?SPEED Study? (Susceptibility Provision Enhances Effective De-escalation) will evaluate whether The Accelerate PhenoTM can effectively change antimicrobial escalation and de-escalation events and thus, clinical management and disease.
Description
A performance verification study with The Accelerate PhenoTM System will potentially address the ongoing concerns with widespread antimicrobial resistance. Our proposed ?SPEED Study? (Susceptibility Provision Enhances Effective De-escalation) will evaluate whether The Accelerate PhenoTM can effectively change antimicrobial escalation and de-escalation events and thus, clinical management and disease.
Details
| Condition | bacteremia |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX8317 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.